Thursday, May 28, 2015 8:48:37 PM
Now as far as the business development update for LymPro, we made significant progress in the last several weeks. We’re under NDA with a number of parties, a number of parties are conducting due diligence on the data that we generated at ICON and are beginning now that the data -- we have the data under confidentiality are beginning to conduct due diligence on the LP-002 study and we’re hopeful to be able to make additional announcements regarding development from the business development area, in and around and following the AAIC meeting. I can’t say anything further beyond that but we’re very pleased with how the business development activity for LymPro is currently going.
Sure sounds like someone is interested in Lympro.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM